共 50 条
ISPAD Clinical Practice Consensus Guidelines 2018: Stages of type 1 diabetes in children and adolescents
被引:79
|作者:
Couper, Jennifer J.
[1
,2
]
Haller, Michael J.
[3
]
Greenbaum, Carla J.
[4
]
Ziegler, Anette-Gabriele
[5
,6
]
Wherrett, Diane K.
[7
]
Knip, Mikael
[8
]
Craig, Maria E.
[9
,10
,11
]
机构:
[1] Womens & Childrens Hosp, Dept Diabet & Endocrinol, Adelaide, SA, Australia
[2] Univ Adelaide, Robinson Res Inst, Adelaide, SA, Australia
[3] Univ Florida, Dept Pediat, Div Endocrinol, Gainesville, FL USA
[4] Benaroya Res Inst, Seattle, WA USA
[5] Tech Univ Munich, Klinikum Rechts Isar, Helmholtz Zentrum Munchen, Inst Diabet Res, Munich, Germany
[6] Tech Univ Munich, Klinikum Rechts Isar, Forschergrp Diabet, Munich, Germany
[7] Univ Toronto, Hosp Sick Children, Dept Pediat, Div Endocrinol, Toronto, ON, Canada
[8] Univ Helsinki, Childrens Hosp, Helsinki, Finland
[9] Childrens Hosp Westmead, Dept Diabet & Endocrinol, Sydney, NSW, Australia
[10] Univ Sydney, Discipline Pediat & Child Hlth, Sydney, NSW, Australia
[11] Univ New South Wales, Sch Womens & Childrens Hlth, Sydney, NSW, Australia
关键词:
BETA-CELL FUNCTION;
HYDROLYZED INFANT FORMULA;
C-PEPTIDE;
HIGH-RISK;
COMBINATION THERAPY;
ISLET AUTOIMMUNITY;
PARTIAL REMISSION;
GENETIC RISK;
DOUBLE-BLIND;
IMMUNE-RESPONSES;
D O I:
10.1111/pedi.12734
中图分类号:
R5 [内科学];
学科分类号:
1002 ;
100201 ;
摘要:
[No abstract available]
引用
收藏
页码:20 / 27
页数:8
相关论文